Genomics England

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Not to be confused with 100K Genome Project.
Genomics England logo.

Genomics England is a company owned by the UK Department of Health. The organisation was set up in order to run the four-year 100,000 Genomes Project, a project using English NHS data to perform whole genome sequencing analysis on 100,000 participant samples. The initial participants were recruited at Cambridge University Hospitals, University College London Partners and Newcastle upon Tyne NHS Foundation Trust. They were joined in the pilot programme shortly after by; Central Manchester University Hospitals NHS Foundation Trust, Great Ormond Street Hospital, Guy's and St Thomas' NHS Foundation Trust, Moorfields Eye Hospital NHS Foundation Trust and Oxford University Hospitals NHS Trust.[1]

History[edit]

Genomics England was established in July 2013 as a company fully owned by the UK Department of Health. The company was launched by Jeremy Hunt, Secretary of State for Health on 5th July, in an announcement timed to coincide with the 65th birthday of the NHS.[2] The Board of Genomics England includes a number of notable scientists, including Sir John Chisholm (former chair of the UK Medical Research Council), Prof. Sir John Bell, Prof. Dame Kay Davies and Prof. Dame Sally Davies.[3] In addition to the delivery of the 100,000 Genomes Project, it is hoped that Genomics England will also mark the beginnings of a UK genomics industry and the start of a personalised medical service.[2] In August 2014, the Wellcome Trust announced that it was investing £27 million in a genome-sequencing hub for Genomics England, allowing the company to become part of the Wellcome Trust Genome Campus, home to the Sanger Institute.[4]

As of 1 August 2014, the 100,000 Genomes Project has passed the 100 genome mark, with the aim of reaching 1,000 by the end of 2014, 10,000 by the end of 2015 and 100,000 by 2017.[5][6] The project is initially focusing on patients with rare diseases and their families, as well as patients with some common types of cancer.

Genomic Medicine Centres[edit]

Following the pilot studies, Genomics England ran a tender to appoint Genomic Medicine Centres with responsibility for recruiting suitable patients, gaining their consent to participate in the project and taking samples for whole genome sequencing by Illumina (company). The successful bidders[7] designated as Genomic Medicine Centres are:


See also[edit]

References[edit]

External links[edit]